Patent Assignment
Reel/Frame 038342/0089
Security Interest
Recorded: 2016-04-21
Pages: 17
Assignor
POZEN INC.
Executed: 2016-02-05
Assignees
DEERFIELD PRIVATE DESIGN FUND III, L.P.
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
DEERFIELD INTERNATIONAL MASTER FUND, L.P.
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
DEERFIELD PARTNERS, L.P.
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties
(35)
Formulation of 5-Ht Agonist and Nsaid for Treatment of Migraine
Patent:
5,872,145 →
Application:
08/907,826 →
Treatment of Migraine Headache
Patent:
6,077,539 →
Application:
08/966,506 →
Anti-Migraine Methods and Compositions Using 5-Ht Agonists with Long-Acting Nsaids
Patent:
6,060,499 →
Application:
09/151,912 →
Treatment of Migraine Headache
Patent:
6,479,551 →
Application:
09/517,751 →
High Potency Dihydroergotamine Compositions
Patent:
6,495,535 →
Application:
09/526,474 →
Methods of Treating Headaches Using 5-Ht Agonists in Combination with Long-Acting Nsaids
Patent:
6,586,458 →
Application:
09/559,753 →
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Treatment of Migraine Headache
High Potency Dihydroergotamine Compositions
Methods of Treating Headaches Using 5-Ht Agonists in Combination with Long-Acting Nsaids
Multilayer Dosage Forms Containing Nsaids and Triptans
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Dosage form for treating gastrointestinal disorders
Application:
11/328,259 →
Publication:
US 2006/0165797
Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an NSAID
Application:
11/331,036 →
Publication:
US 2006/0178348
Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
Application:
11/332,795 →
Publication:
US 2006/0178349
Dosage forms for administering combinations of drugs
Application:
11/712,969 →
Publication:
US 2007/0207200
Dosage forms for administering combinations of drugs
Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof
Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
Application:
12/553,804 →
Publication:
US 2010/0172983
Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
Method for Treating a Patient in Need of Aspirin Therapy
Application:
12/823,082 →
Publication:
US 2011/0008432
Methods of Treating Headaches Using 5-Ht Agonists in Combination with Long-Acting Nsaids
Application:
13/183,983 →
Publication:
US 2011/0275691
Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs
Method for Treating a Patient in Need of Aspirin Therapy
Application:
13/345,075 →
Publication:
US 2012/0177736
Pharmaceutical Compositions For The Coordinated Delivery Of NSAIDs
Application:
13/475,446 →
Publication:
US 2013/0078305
Methods of Treating Headaches Using 5-Ht Agonists in Combination with Long-Acting Nsaids
Application:
13/872,832 →
Publication:
US 2013/0303583
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Controlled Dosing of Clopidogrel with Gastric Acid Inhibition Therapies
Application:
14/344,688 →
Publication:
US 2015/0079169
Phased Dosing of Clopidogrel
Application:
14/344,699 →
Publication:
US 2015/0024042
Compositions and Methods for Delivery of Omeprazole Plus Acetylsalicylic Acid
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Method for Treating a Patient at Risk for Developing an Nsaid-Associated Ulcer
Application:
14/593,212 →
Publication:
US 2015/0202193
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 24, 2010
From: ORLEMANS, EVERARDUS; PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 023987/0300 →
Assignment of Assignor's Interest
Feb 24, 2010
From: ASTRAZENECA UK LIMITED
To: POZEN INC.
Reel/Frame 023987/0309 →
Assignment of Assignor's Interest
Feb 24, 2010
From: ASTRAZENECA PHARMACEUTICALS LP
To: ASTRAZENECA UK LIMITED
Reel/Frame 023987/0303 →
Assignment of Assignor's Interest
Feb 24, 2010
From: AULT, BRIAN; SOSTEK, MARK
To: ASTRAZENECA R&D WILMINGTON
Reel/Frame 023987/0290 →
Assignment of Assignor's Interest
Feb 24, 2010
From: POZEN INC.
To: ASTRAZENECA UK LIMITED
Reel/Frame 023987/0313 →
Assignment of Assignor's Interest
Sep 21, 2010
From: PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 025018/0326 →
Assignment of Assignor's Interest
Oct 7, 2010
From: PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 025110/0242 →
Corrective Assignment to Correct the Receiving Party Name Should Be Astrazeneca Pharmaceuticals Lp Previously Recorded on Reel 023987 Frame 0290. Assignor(S) Hereby Confirms the Receiving Party Name Should Be Changed from Astrazeneca R&D Wilmington to Astrazeneca Pharmaceuticals Lp.
Feb 16, 2011
From: AULT, BRIAN; SOSTEK, MARK
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 025810/0644 →
Assignment of Assignor's Interest
Aug 28, 2012
From: ORLEMANS, EVERARDUS; PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 028860/0880 →
Assignment of Assignor's Interest
Aug 28, 2012
From: ASTRAZENECA PHARMACEUTICALS LP
To: ASTRAZENECA UK LIMITED
Reel/Frame 028860/0940 →
Assignment of Assignor's Interest
Aug 28, 2012
From: AULT, BRIAN; HWANG, CLARA; SOSTEK, MARK
To: ASTRAZENECA PLP
Reel/Frame 028860/0759 →
Assignment of Assignor's Interest
Aug 28, 2012
From: ASTRAZENECA AB
To: ASTRAZENECA AB; POZEN INC.
Reel/Frame 028861/0066 →
Assignment of Assignor's Interest
Aug 28, 2012
From: POZEN INC.
To: ASTRAZENECA AB
Reel/Frame 028861/0035 →
Assignment of Assignor's Interest
Aug 28, 2012
From: ASTRAZENECA UK LIMITED
To: ASTRAZENECA AB
Reel/Frame 028860/0990 →
Assignment of Assignor's Interest
Oct 11, 2012
From: ASTRAZENECA UK LIMITED; POZEN INC.
To: ASTRAZENECA AB
Reel/Frame 029113/0459 →
Security Agreement
Apr 8, 2013
From: MITEL NETWORKS CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 030186/0894 →
Assignment of Assignor's Interest
Dec 12, 2013
From: ASTRAZENECA AB
To: HORIZON PHARMA USA, INC.
Reel/Frame 031770/0398 →
Assignment of Assignor's Interest
Dec 12, 2013
From: ASTRAZENECA AB
To: HORIZON PHARMA USA, INC.
Reel/Frame 031770/0611 →
Patent Security Agreement
Nov 10, 2014
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 034197/0415 →
Security Interest
May 7, 2015
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 035591/0028 →
Release of Security Interest
May 7, 2015
From: CITIBANK, N.A.
To: HORIZON PHARMA USA, INC.
Reel/Frame 035590/0194 →
Corrective Assignment to Correct the Incorrect Execution Date Previously Recorded at Reel: 035591 Frame: 0028. Assignor(S) Hereby Confirms the Security Interest.
Aug 6, 2015
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 036303/0708 →
Assignment of Assignor's Interest
Jul 24, 2018
From: POZEN, INC.
To: GENUS LIFESCIENCES, INC.
Reel/Frame 046445/0466 →
Assignment of Assignor's Interest
Jul 26, 2018
From: HORIZON PHARMA USA, INC.
To: HORIZON MEDICINES LLC
Reel/Frame 046465/0336 →
Release of Security Interest
Aug 6, 2018
From: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD PARTNERS, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.
To: POZEN, INC.
Reel/Frame 046562/0778 →